These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 36727070)
1. A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis. Li R; Chen W; Lu C; Li X; Chen X; Huang G; Wen Z; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Ni L; Lai Y Front Oncol; 2022; 12():1076303. PubMed ID: 36727070 [TBL] [Abstract][Full Text] [Related]
2. A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma. Li R; Lu C; Li X; Chen X; Huang G; Wen Z; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Lai Y Front Genet; 2022; 13():897827. PubMed ID: 35938021 [No Abstract] [Full Text] [Related]
3. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma. Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891 [TBL] [Abstract][Full Text] [Related]
4. A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma. Wen Z; Li Y; Zhao Z; Li R; Li X; Lu C; Sun C; Chen W; Ge Z; Ni L; Lai Y Cancer Cell Int; 2024 Jan; 24(1):18. PubMed ID: 38191389 [TBL] [Abstract][Full Text] [Related]
5. Identification of a four-microRNA panel in serum for screening renal cell carcinoma. Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264 [TBL] [Abstract][Full Text] [Related]
6. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test. Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801 [TBL] [Abstract][Full Text] [Related]
8. Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma. Huang G; Li H; Wang J; Peng X; Liu K; Zhao L; Zhang C; Chen X; Lai Y; Ni L Pathol Res Pract; 2020 Nov; 216(11):153152. PubMed ID: 32823234 [TBL] [Abstract][Full Text] [Related]
9. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679 [TBL] [Abstract][Full Text] [Related]
10. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection. Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390 [TBL] [Abstract][Full Text] [Related]
11. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985 [TBL] [Abstract][Full Text] [Related]
12. A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma. Li H; Huang G; Lai Y; Ni L; Lai Y Oncol Res Treat; 2022; 45(6):344-352. PubMed ID: 35231919 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis. Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W Gene; 2020 Feb; 727():144243. PubMed ID: 31743768 [TBL] [Abstract][Full Text] [Related]
14. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma. Xiao CT; Lai WJ; Zhu WA; Wang H Onco Targets Ther; 2020; 13():10765-10774. PubMed ID: 33122915 [TBL] [Abstract][Full Text] [Related]
16. A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma. Li R; Lu C; Yang W; Zhou Y; Zhong J; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Hu H; Lai Y J Clin Lab Anal; 2022 Feb; 36(2):e24194. PubMed ID: 35028969 [TBL] [Abstract][Full Text] [Related]
17. A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis. Li R; Chen X; Li X; Huang G; Lu C; Wen Z; Chen Z; Lai Y Am J Transl Res; 2022; 14(7):4606-4616. PubMed ID: 35958461 [TBL] [Abstract][Full Text] [Related]
18. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma. Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286 [TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis. Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H Front Immunol; 2018; 9():3099. PubMed ID: 30687316 [TBL] [Abstract][Full Text] [Related]
20. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]